Nitric oxide and vascular reactivity in African American patients with hypertension

J Card Fail. 2003 Oct;9(5 Suppl Nitric Oxide):S199-204; discussion S205-9. doi: 10.1054/s1071-9164(03)00588-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • African Americans*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Brachial Artery / physiopathology
  • Carbazoles / therapeutic use
  • Carotid Arteries / physiopathology
  • Carvedilol
  • Continental Population Groups
  • Coronary Vessels / physiopathology
  • Drug Resistance
  • Endothelium / metabolism*
  • European Continental Ancestry Group
  • Glucose-6-Phosphatase / metabolism
  • Humans
  • Hypertension / drug therapy
  • Hypertension / ethnology*
  • Hypertension / physiopathology*
  • Inflammation / physiopathology
  • Isoproterenol / pharmacology
  • Methacholine Chloride / pharmacology
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type III
  • Nitroglycerin / pharmacology
  • Nitroprusside / pharmacology
  • Propanolamines / therapeutic use
  • Prosencephalon / blood supply
  • Regional Blood Flow / drug effects
  • Risk Factors
  • Vascular Resistance

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Methacholine Chloride
  • Nitroprusside
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Glucose-6-Phosphatase
  • Nitroglycerin
  • Isoproterenol